Lincomycin
Paul G. Auwaerter, M.D., Edina Avdic, Pharm.D.
Pediatric Dosing Author: Taylor Imburgia, PharmD, BCPPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Treatment of serious infections caused by susceptible strains of streptococci, pneumococci, and staphylococci in PCN-allergic patients.
- Only IV formulation is available in the U.S.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved